Why we invested

Alzheimer's disease and other dementia variants are a major global health issue. In the U.S. alone, over 56 million people are at risk, with an estimated 6-7 million potentially treatable cases remaining unidentified. Accurate diagnosis after initial screening requires a brain scan using PET technology, as current paper tests are unreliable. Existing imaging options, like PET/CT, are too costly and used for other disorders, leading to a diagnostic bottleneck. The economic burden is substantial, with costs in the hundreds of billions annually, highlighting the urgent need not only for treatment, but for accurate diagnostics.

Positrigo’s unique solution offers a compact scanner, based on the Positron Emitting Tomography (PET) technology. By applying precision engineering techniques, they managed to miniaturize a multi-million machine that typically occupies 30 square meters and weight a few tons, into a single chair that is highly affordable and is easily installed into a neurologist practice.

Founding team